https://www.selleckchem.com/pr....oducts/abraxane-nab-
RESULTS In the analysis, despite a noticeable trend, all-cause mortality rates were not found to be statistically significantly higher among the 35 patients who registered positive results using 99mTc-HMPAO-SPECT/CT for CDRIE (group 1) than among the 68 patients from group 2 whose 99mTc-HMPAO-SPECT/CT results were negative (20% vs. 10.3%, respectively; p = 0.14). However, group 1 did present higher in-hospital mortality (11.4% vs. 0%, respectively; odds ratio 19.6; 95% confidence interval [CI] 1.02 to 374.7, an increas
Beğen
Yorum Yap
Paylaş
